Brown MJ - Search Results

1

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ; British Hypertension Society's PATHWAY Studies Group. Williams B, et al. Among authors: brown mj. Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20. Lancet. 2015. PMID: 26414968 Free PMC article. Clinical Trial.

2

Efficacy and tolerance of doxazosin: a review.

Brown MJ. Brown MJ. J Hum Hypertens. 1990 Oct;4 Suppl 3:34-8. J Hum Hypertens. 1990. PMID: 2148193 Review.

3

Functioning middle mediastinal paraganglioma (phaeochromocytoma) associated with intercarotid paragangliomas.

Dunn GD, Brown MJ, Sapsford RN, Mansfield AO, Hemingway AP, Sever PS, Allison DJ. Dunn GD, et al. Among authors: brown mj. Lancet. 1986 May 10;1(8489):1061-4. doi: 10.1016/s0140-6736(86)91331-0. Lancet. 1986. PMID: 2871337

4

Angiotensin-converting enzyme and the cough reflex.

Morice AH, Lowry R, Brown MJ, Higenbottam T. Morice AH, et al. Among authors: brown mj. Lancet. 1987 Nov 14;2(8568):1116-8. doi: 10.1016/s0140-6736(87)91547-9. Lancet. 1987. PMID: 2890021 Clinical Trial.

5

Alpha-blockade and calcium antagonism: an effective and well-tolerated combination for the treatment of resistant hypertension.

Brown MJ, Dickerson JE. Brown MJ, et al. J Hypertens. 1995 Jun;13(6):701-7. doi: 10.1097/00004872-199506000-00018. J Hypertens. 1995. PMID: 7594429 Clinical Trial.

6

Angiotensin receptor blockers in essential hypertension.

Brown MJ. Brown MJ. Lancet. 1993 Dec 4;342(8884):1374-5. doi: 10.1016/0140-6736(93)92745-f. Lancet. 1993. PMID: 7901674 No abstract available.

7

Bovril and moclobemide: a novel therapeutic strategy for central autonomic failure.

Karet FE, Dickerson JE, Brown J, Brown MJ. Karet FE, et al. Among authors: brown mj, brown j. Lancet. 1994 Nov 5;344(8932):1263-5. doi: 10.1016/s0140-6736(94)90752-8. Lancet. 1994. PMID: 7967987

8

Irbesartan treatment in hypertension.

Brown MJ. Brown MJ. Hosp Med. 1998 Oct;59(10):808-11. Hosp Med. 1998. PMID: 9850301 Review.

9

Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ. Dickerson JE, et al. Among authors: brown mj. Lancet. 1999 Jun 12;353(9169):2008-13. doi: 10.1016/s0140-6736(98)07614-4. Lancet. 1999. PMID: 10376615 Clinical Trial.

10

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Brown MJ, et al. Lancet. 2000 Jul 29;356(9227):366-72. doi: 10.1016/S0140-6736(00)02527-7. Lancet. 2000. PMID: 10972368 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,243 results

Search Page

Filters